Review Article

Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia

Table 2

BCR-ABL signaling pathways affected by Hsp90 inhibitors.

S. numberName of the compoundIsolated fromNature of originMechanism of inhibition of Hsp90Signaling protein downregulated by Hsp90 inhibitorsReferences

1GeldanamycinStreptomyces hygroscopicusBacterialBinds to N-terminal domain of Hsp90↓ c-Raf,
↓ Akt,
↓ BCR-
ABL
[74]

2RadicicolDiheterospora chlamydosporia and Monosporium bonordenFungalBinds to N-terminal domain of Hsp90↓ p-Raf1,
↓ p-BCR-
ABL
[90]

3NovobiocinStreptomyces spheroidsBacterialBinds to C-terminal domain of Hsp90↓ p-Akt,
↓ p-ERK &
↓ p-BCR-
ABL
[91, 92]

4Epigallocatechin-3-gallateCamellia sinensisPlantBinds to C-terminal domain of Hsp90↓ CyclinD1,
↓ CDC25A
[96]

5TaxolTaxus baccata L.PlantNYK↓ pSTAT3,
↓ pSTAT5,
↓ p-CRKL,
↓ p-Lyn
[101]

6Gambogic acidGarcinia hanburyiPlantBinds to N-terminal domain of Hsp90↓ p-BCR-
ABL
↓ pSTAT5,
↓ p-CRKL,
↓ pERK1/2,
↓ p-Akt &
↓ p-BCR-
ABL
[103, 104]

7CelastrolTripterygium wilfordii Hook FPlantDisrupts binding of Cdc37 to Hsp90↓ pSTAT5,
↓ p-CRKL,
↓ pERK1/2,
↓ p-Akt,
↓ p-BCR-
ABL,
↓ Bcl-xL,
↓ Mcl-1,
↓ survivin
[107, 108]

8CurcuminCurcuma aromatica, Curcuma longa, and Curcuma phaeocaulisPlantNYK↓ BCR-
ABL,
↓ CRKL,
↓ STAT5
[110, 111]

9Withaferin AWithania somniferaPlantDisrupts the binding of Cdc37 to Hsp90 ↓ NFκB,
↓ Bcl-2,
↓ Bim,
↓ p-Bad
[114, 115]

105-Episinuleptolide acetateSinularia speciesCoralNYK↓ c-ABL,
↓ Akt,
↓ NFκB
[116]

NYK: not yet known.